Business · 08/07/2002Updated: 10/17/2026 · 1 min read
FDA Announces Approval of Guidance for Fast Track Drug Development Programs
Summary
The Food and Drug Administration (FDA) has announced that it has received approval from the Office of Management and Budget (OMB) for a collection of information related to its guidance on fast track drug development programs, as required by the Paperwork Reduction Act of 1995.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →